ArnoldLLentnekMD

Infectious Disease • Boca Raton, FL

Physician

Join to view full profile

Dr. Lentnek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lentnek's full profile

Already have an account?

Office
17087 Ryton Lane
Boca Raton, FL 33496
Phone+1 404-798-7152

Education & Training

University of Pennsylvania Health SystemFellowship, Infectious Disease, 1973 - 1975
University of Pennsylvania Health SystemResidency, Internal Medicine, 1973 - 1975
George Washington UniversityResidency, Internal Medicine, 1972 - 1973
University of ConnecticutResidency, Internal Medicine, 1969 - 1970
Hartford HospitalInternship, Transitional Year, 1968 - 1969
Tufts University School of MedicineClass of 1968

Certifications & Licensure

NY State Medical License 1971 - 2026
NJ State Medical License 1990 - 2025
GA State Medical License 1993 - 2021
CT State Medical License 1971 - 2016
PA State Medical License 1973 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
National Board of Physicians and Surgeons Infectious Disease
National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

Teacher of the Year AOA, 2009

Clinical Trials

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis Start of enrollment: 2004 Jan 01
Completed
Phase 2

Publications & Presentations

PubMed

54 citations
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
Martin E. Stryjewski, Arnold Lentnek, William O'Riordan, John Pullman, Paul A. Tambyah
BMC Infectious Diseases. 2014-05-23
15 citations
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.
Martin E. Stryjewski, Steven L. Barriere, Ethan Rubinstein, Fredric C. Genter, Arnold Lentnek
International Journal of Antimicrobial Agents. 2013-10-01
7 citations
Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physici...
Alexander J. Kallen, Susan E. Beekmann, Brandi Limbago, Arnold L. Lentnek, Philip M. Polgreen
Diagnostic Microbiology and Infectious Disease. 2011-11-01

Industry Relationships

Consultant, Gerson Lehrman Group2010 - Present
Consultant, Guidepoint Global2010 - Present
Consultant, Senzar Capital Management2008 - Present